Presentation TCT 2019 SSO2 Therapy: Clinical Evidence and Outcomes Presenter: Gregg Stone September 26, 2019
Presentation TCT 2019 SuperSaturated Oxygen Therapy: Background and Mechanism of Action Presenter: James Spears September 26, 2019
Presentation TCT 2019 Failed Therapeutic Approaches (Drugs and Devices) to Reduce Infarct Size Presenter: E. Magnus Ohman September 26, 2019
Presentation TCT 2019 Importance of Infarct Size and Microvascular Obstruction in STEMI Presenter: Suzanne de Waha September 26, 2019
News Conference News TCT 2019 Strokes Increasing in STEMI Patients With Cardiogenic Shock Todd Neale September 25, 2019
Presentation TCT 2019 Case Resolution: How Did I Treat This Patient? Presenter: Chaim Lotan September 25, 2019
Presentation TCT 2019 How I Would Treat This Case Presenter: Mohamed Abed Bouraghda September 25, 2019
Presentation TCT 2019 TCT 106: FFR in non-culprits in STEMI: a substudy of the COMPARE-ACUTE trial Presenter: Zsolt Piroth September 25, 2019
Presentation TCT 2019 Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI Presenter: Gregory Serrao September 25, 2019
News Industry News CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019 September 25, 2019
News Daily News CMR May Help Evaluate Nonculprit Lesions in STEMI Patients Todd Neale September 19, 2019
News Opinion Fellow Talk What I Am Most Looking Forward to at TCT 2019 Mahesh V. Madhavan, MD September 18, 2019
News Conference News ESC 2019 BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI Caitlin E. Cox September 10, 2019
News Conference News ESC 2019 GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS Yael L. Maxwell September 10, 2019